Skip to main content
. 2020 Jul 26;5(4):e000744. doi: 10.1136/esmoopen-2020-000744

Figure 2.

Figure 2

Overview of the Multipli WES/RNASeq Platforms Workflow Study. C-DNA, constitutional DNA; D 0, Day 0; mCRC, metastatic colorectal carcinoma; MTB, Molecular Tumour Board; STS, soft tissue sarcoma; T-DNA, tumour DNA; T-RNA, tumour RNA; WES/RNASeq, whole exome sequencing and RNA sequencing.